Stanley Center for the Innovative Treatment of Bipolar Disorder

THIRD INTERNATIONAL CONFERENCE 
ON BIPOLAR DISORDER



Introduction

Proceedings

Bipolar Conferences Home

Session I: "Treatment of Bipolar Depression:  A Review of New Approaches"
Chair: Ellen Frank, Ph.D.


Interpersonal and Social Rhythm Therapy Prevents Depressive Symptomatology in Bipolar I Patients

Ellen Frank, Ph.D.
Bibliography

Slide Presentation

Abstract
For much of the first two decades of lithium treatment, bipolar disorder was thought of as a problem solved; however, more recent controlled trials (e.g. Prien et al., 1984; Gelenberg et al., 1989) and descriptive studies (Markar and Mandar 1989; Goldberg et al., 1995) point to the relatively poor long-term prognosis for many bipolar I patients.

In particular, effective treatment of bipolar depression has proven a major challenge. We have conducted a randomized controlled trial comparing protocol pharmacotherapy in the context of an intensive clinical management (ICM) paradigm with protocol pharmacotherapy combined with interpersonal and social rhythm therapy (Frank et al., 1994). While the two approaches seem equally effective in preventing recurrence of fully syndromal mania or depression, we are also interested in the impact of these two treatment approaches on subsyndromal symptomatology. In this presentation we report on the first year of preventative maintenance treatment for the first 90 subjects randomly assigned to one of these two maintenance treatment conditions.

Fluctuation of symptoms during the preventative phase of the trial was examined by defining the symptomatic state of each subject for each month. Monthly states were based upon the maximum score of each month for every subject. The states were defined as euthymic (Hamilton < 8 and Bech-Rafaelsen < 4), depressed (Hamilton > 8 and Bech-Rafaelsen < 4) and manic/mixed (Bech-Rafaelsen > 5).

A mixed-effects nominal logistic regression using MIXNO (Hedeker, 1998) was used to compare the states of subjects in the two different treatment conditions during the first year of preventative maintenance. The MIXNO program provides maximum marginal likelihood estimates for the mixed-effects model utilizing a Fisher-scoring solution. Each subject was treated as a random effect by defining intercept as a random effect. Month (0 through 12) and treatment group (IPSRT or ICM) were treated as fixed effects. A fixed effect of month by treatment interaction was also included to assess the difference in proportions of subjects in a particular state as a function of time.

There was a significant month (p < .02) and month by treatment interaction (p < .0005) when comparing the depressed state to the euthymic state, such that the IPSRT group is significantly more likely to remain in the euthymic state, while the proportion of the ICM group in the euthymic state decreases over time and the proportion in the depressive state increases over time. There was no significant difference comparing the manic/mixed state to the euthymic state.

We conclude the IPSRT may have an important role in preventing subsyndromal depression in bipolar I patients and, thus, in improving the quality of long-term remission they experience. It remains to be seen whether prevention of subsyndromal depression is associated with a reduced risk of depressive recurrence.


Multifamily Group Treatment for Bipolar Depression

Gabor I. Keitner, M.D.
Bibliography

Slide Presentation

Abstract
The treatment of bipolar depression continues to present a clinical challenge. Episodes of depression seem more resistant to available pharmacological treatments than do manic episodes. This presentation will describe a standardized 6 session multifamily psychoeducational group treatment program that is currently being tested in the treatment of bipolar disorder. Group formation, therapist training and the content of the family group treatment will be reviewed.

Preliminary results will be presented from a study of 92 hospitalized bipolar patients (75% manic, 20% depressed, 5% mixed) treated with pharmacology alone vs. pharmacology with individual family therapy vs. pharmacology with multifamily psychoeducational group therapy. The focus will be on bipolar patients who were depressed at the index episode.


Treatment of Bipolar Depression

Gary S. Sachs, M.D.
Bibliography

Slide Presentation

Abstract
The high risk of suicide in depressed Bipolar patients presents a compelling need for antidepressant treatment, but risk of poor outcome is high. Response rates to standard antidepressant medications appear substantially lower in bipolar patients than in unipolar depression. Furthermore standard antidepressant medications may worsen the course of bipolar illness. Use of antidepressants is complicated by the risk of mania during the course of treatment and during withdrawal of treatment. In addition, Altshuler et al have shown antidepressant medications may accelerate cycling even without induction of abnormal mood elevation. Therefore, clinicians treating bipolar depresion face a dilemma as they balance the risks and benefits of treatment with antidepressant mediation.

This presentation will offer guidelines for management of bipolar depression which uses four principles to manage the risk of antidepressant medication: 1) Initiate acute phase treatment with mood stabilizing agents, 2) if necessary offer standard antidepressant medications proceeding stepwise from agents with lower risk (bupropion) to higher medications (tricyclics), 3) minimize antidepressant exposure by attempting a gradual taper after appropriate continuation phase treatment, and 4) offer ECT for patients at immediate risk of self harm or unable to tolerate pharmacological interventions.

Sachs GS: Treatment Refractory Bipolar Depression: In Psychiatric
Clinics of North America, Amsterdam J, and Rohan M (Eds), Philadelphia, W.B.Saunders, 1996

Sachs GS, Bipolar Mood Disorder: Practical Strategies for Acute and
Maintenance Phase Treatment, J. Clin Psychopharm (suppl) 16: 32s-47s, 1996

Top of Page


Introduction | Proceedings | Bipolar Conferences Home

© The Department of Psychiatry, University of Pittsburgh School of Medicine